Please ensure Javascript is enabled for purposes of website accessibility
Inicio > Productos > Kits de Ensayo > Kits de Ensayo ADA

Research Reagents & Products

ADA Assay Kits

Assess immunogenicity with validated ADA assay kits — bridging ELISA format for anti-drug antibody screening, confirmation, and titration. Compatible with major biologic drug classes.RUO

¿Por qué los investigadores eligen abinScience?

Comodidad de uso inmediato Pre-coated plates, optimized buffers, and step-by-step protocols — reliable results in 3–5 hours.
Alta sensibilidad Detection limits as low as1–15 pg/mL depending on the analyte, with excellent linearity.
Reproducible y fiable CV <10% intra-assay, <15% inter-assay. Every kit lot is QC-tested before release.
Pares de anticuerpos emparejados Capture and detection antibodies optimized together for maximum signal-to-noise ratio
Contenido completo del kit Standards, detection reagents, substrate, stop solution, and plate sealers included — no hidden extras.

ドキュメントとQCデータ

Download kit manuals, standard curves, CoA, and troubleshooting guides on each product page. Todos los documentos son específicos del lote y están disponibles en formato PDF.

Preguntas frecuentes (FAQ)

¿Qué tipos de muestras son compatibles?

Most kits work with serum, plasma, cell culture supernatant, and tissue lysate. Specific validated sample types are listed in each kit manual.

¿Qué sensibilidad tienen sus kits de ELISA?

Typical sensitivity ranges from 1–15 pg/mL depending on the analyte. Each kit datasheet specifies the exact minimum detectable dose (MDD).

¿Cuánto tiempo dura el ensayo?

Standard sandwich ELISA protocols complete in 3–5 hours. Some kits offer rapid formats finishing in under 90 minutes.

¿Los kits incluyen estándares y controles?

Yes — all kits include lyophilized standards, detection reagents, substrate, and stop solution. Positive controls are included in select kits.

¿Puedo utilizar sus kits para la detección múltiple?

Our standard kits are singleplex. For multiplex needs, individual kit components can often be adapted. Contact us for guidance on panel design.

Opciones+
Opciones
Confirmar
  • Tipos de productos
    0 seleccionado
    Assay Kit (337)
  • Objetivo
    0 seleccionado
    Clazakizumab (1)
    Ibritumomab (1)
    Conatumumab (1)
    Balstilimab (1)
    Olaratumab (1)
    Certolizumab (2)
    Tarextumab (1)
    Cabiralizumab (1)
    Tisotumab (1)
    Oleclumab (1)
    Vanucizumab (1)
    CD79B (2)
    Concizumab (1)
    Letolizumab (1)
    Bevacizumab (3)
    Dupilumab (3)
    Serclutamab (1)
    Tibulizumab (1)
    Rafivirumab (1)
    Elotuzumab (1)
    RBD (Delta) (2)
    CD20/MS4A1 (3)
    A29L (4)
    Tirzepatide (1)
    Enfortumab (1)
    Denosumab (3)
    Astegolimab (1)
    Olokizumab (1)
    Mosunetuzumab (1)
    Mavezelimab (1)
    Drozitumab (1)
    Alacizumab (1)
    Eldelumab (1)
    Cetrelimab (1)
    Sacituzumab (1)
    Tovetumab (1)
    Emactuzumab (1)
    Disitamab (1)
    Afasevikumab (1)
    Marstacimab (1)
    Rolinsatamab (1)
    Basiliximab (1)
    Amatuximab (1)
    Apamistamab (1)
    Brolucizumab (1)
    Vunakizumab (1)
    Evolocumab (1)
    Dilpacimab (1)
    Spike glycoprotein (10)
    Frovocimab (1)
    M1R (4)
    Nirsevimab (1)
    Romiplostim (1)
    Cetuximab (3)
    Exenatide acetate (2)
    Iscalimab (1)
    Tesidolumab (1)
    Sirukumab (1)
    Ocaratuzumab (1)
    Favezelimab (1)
    Lexatumumab (1)
    Ramucirumab (1)
    Nivolumab (3)
    Bimagrumab (1)
    Golimumab (3)
    Urelumab (1)
    Imalumab (1)
    Zampilimab (1)
    Lupartumab (1)
    Ivuxolimab (1)
    Pertuzumab (3)
    Bimekizumab (1)
    Itolizumab (1)
    Camidanlumab (1)
    Anetumab (1)
    Ranibizumab (3)
    Tosatoxumab (1)
    Alirocumab (1)
    Navicixizumab (1)
    Spike Protein (Trimer) (2)
    Guselkumab (3)
    Lodelcizumab (1)
    Mazdutide (1)
    Palivizumab (3)
    Ianalumab (1)
    Sarilumab (2)
    Varisacumab (1)
    Belantamab (1)
    Ziltivekimab (1)
    Tigatuzumab (1)
    Lenzilumab (1)
    Pembrolizumab (3)
    Semorinemab (1)
    Ipilimumab (2)
    Utomilumab (1)
    Cixutumumab (1)
    Pogalizumab (1)
    Trastuzumab (2)
    Ixekizumab (1)
    Obinutuzumab (2)
    Anifrolumab (1)
    Daclizumab (1)
    Emibetuzumab (1)
    Retatrutide (1)
    Tiragolumab (2)
    RBD (Omicron/BA.5) (3)
    NP/Nucleocapsid (3)
    H3L (2)
    Suptavumab (1)
    Sotrovimab (1)
    Ontamalimab (1)
    Varlilumab (1)
    Tanezumab (1)
    Teclistamab (1)
    Carlumab (1)
    Indatuximab (1)
    Ascrinvacumab (1)
    Namilumab (1)
    Sintilimab (1)
    Tilavonemab (1)
    Tremelimumab (1)
    Daratumumab (3)
    Infliximab (2)
    Dalotuzumab (1)
    Andecaliximab (1)
    Vofatamab (1)
    Depatuxizumab (1)
    Tavolimab (1)
    Zanidatamab (1)
    Afutuzumab (1)
    Cusatuzumab (1)
    Blosozumab (1)
    Ustekinumab (3)
    β-D-Glucan (1)
    Obiltoxaximab (1)
    dsDNA (1)
    Atezolizumab (3)
    Etanercept (1)
    Tezepelumab (1)
    E8L (4)
    Casirivimab (1)
    Vorsetuzumab (1)
    Ibalizumab (1)
    Tocilizumab (3)
    Crizanlizumab (1)
    Cergutuzumab (1)
    Otilimab (1)
    Tislelizumab (1)
    Zagotenemab (1)
    Zalifrelimab (1)
    Magrolimab (1)
    Figitumumab (1)
    Losatuxizumab (1)
    Lirilumab (1)
    Icrucumab (1)
    Benufutamab (1)
    Romosozumab (1)
    Enoblituzumab (1)
    Glycoprotein (4)
    Avelumab (3)
    Rituximab (1)
    A35R (4)
    Remtolumab (1)
    Suvizumab (1)
    Imdevimab (1)
    Tregalizumab (1)
    Glembatumumab (1)
    Inclacumab (1)
    Talacotuzumab (1)
    Adalimumab (3)
    Pasotuxizumab (1)
    Labetuzumab (1)
    Lorvotuzumab (1)
    Lintuzumab (1)
    Faricimab (1)
    Cinpanemab (1)
    Toripalimab (1)
    Ifabotuzumab (1)
    Canakinumab (1)
    Ganitumab (1)
    Farletuzumab (1)
    Oxelumab (1)
    Necitumumab (1)
    Zenocutuzumab (1)
    Epcoritamab (1)
    F/Fusion glycoprotein F0 (3)
    Omalizumab (2)
    Siltuximab (3)
    Mirzotamab (1)
    Gremubamab (1)
    Semaglutide (1)
    Durvalumab (3)
    Elezanumab (1)
    Eculizumab (3)
    Secukinumab (2)
    Glofitamab (1)
    Ieramilimab (1)
    Meplazumab (1)
    Zanolimumab (1)
    Lacnotuzumab (1)
    Vibecotamab (1)
    Rosopatamab (2)
    Nesvacumab (1)
    Milatuzumab (1)
    Befovacimab (1)
    Edrecolomab (1)
    Gevokizumab (1)
    Sibrotuzumab (1)
    Teprotumumab (1)
    Mirvetuximab (1)
    Panitumumab (3)
    Codrituzumab (1)
    Foravirumab (1)
    Mirikizumab (2)
    RBD (4)
    Omburtamab (1)
    GP/Envelope glycoprotein (3)
    Pacmilimab (1)
    Natalizumab (2)
    Glycoprotein G (2)
  • Aplicaciones
    0 seleccionado
    ELISA (337)